Clinical Effect of Xiaozhi Hugan Capsules in Treatment of Patients with Non-alcoholic Steatohepatitis and Its Impact on Serum IL-6 and MCP-1
|更新时间:2025-05-16
|
Clinical Effect of Xiaozhi Hugan Capsules in Treatment of Patients with Non-alcoholic Steatohepatitis and Its Impact on Serum IL-6 and MCP-1
“According to the latest report, a study conducted by the First Affiliated Hospital of Henan University of Traditional Chinese Medicine shows that Xiaozhi Hugan Capsules have significant therapeutic effects on patients with phlegm dampness stasis type non-alcoholic fatty liver disease. They can reduce liver hardness, inhibit the expression of inflammatory factors, and have no significant adverse reactions.”
Chinese Journal of Experimental Traditional Medical FormulaeVol. 31, Issue 12, Pages: 185-192(2025)
LIU Xiaoyan,MA Suping,MA Qingliang,et al.Clinical Effect of Xiaozhi Hugan Capsules in Treatment of Patients with Non-alcoholic Steatohepatitis and Its Impact on Serum IL-6 and MCP-1[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(12):185-192.
LIU Xiaoyan,MA Suping,MA Qingliang,et al.Clinical Effect of Xiaozhi Hugan Capsules in Treatment of Patients with Non-alcoholic Steatohepatitis and Its Impact on Serum IL-6 and MCP-1[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(12):185-192. DOI: 10.13422/j.cnki.syfjx.20251198.
Clinical Effect of Xiaozhi Hugan Capsules in Treatment of Patients with Non-alcoholic Steatohepatitis and Its Impact on Serum IL-6 and MCP-1